PsoProtectMe當前資料的概述
當前資料
我們致力於分享PsoProtectMe摘要資料。這些資料是初步的,包括有限數量的參與者,因此不應用於指導臨床決策。
Click here to read our research paper detailing PsoProtect data. A summary can be found on the Psoriasis Association website here.
Our research paper detailing shielding behaviour can be found here. A summary can also be found on the Psoriasis Association website here.
See our full list of research publications here.
0
PsoProtectMe調查完成
來自PsoProtectMe的前5360名參與者的摘要資料。
每個大洲的參與者(總共39個國家):
Country | Participants | Country | Participants |
---|---|---|---|
Argentina | 227 | Netherlands | 53 |
Australia | 44 | Norway | 31 |
Brazil | 158 | Panama | 11 |
Canada | 66 | Paraguay | 15 |
Chile | 479 | Peru | 19 |
Denmark | 55 | Philippines | 59 |
Dominican Republic | 10 | Poland | 106 |
France | 14 | Portugal | 298 |
Greece | 15 | Singapore | 17 |
Hong Kong | 18 | South Africa | 18 |
India | 54 | Spain | 80 |
Ireland | 73 | Sweden | 64 |
Italy | 80 | United Kingdom | 2641 |
Japan | 110 | United States | 355 |
Malaysia | 12 | Other (<10) | 157 |
Mexico | 11 |
平均年齡:45 歲(範圍3-91)
平均身體質量指數: 26.8 公斤/平方尺
乾癬的類型:4408尋常型乾癬,1122點滴型乾癬,289膿皰型乾癬,120紅皮病
性别:
吸煙狀況:
乾癬及乾癬性關節炎並存:
乾癬的治療類型:
大流行期間乾癬嚴重程度的變化:
您是否已被診斷出或認為自己患有新冠狀病毒?
您有否因新型冠狀病毒去過急診室?
您有否因新型冠状病毒住院?
您的新型冠狀病毒感染病好了嗎?